FDX1 and hepatocellular carcinoma: A study by Sun et al. found that the downregulation of FDX leads to ROS-mediated mitochondrial autophagy and activation of the PI3K/AKT signaling pathway, promoting HCC cell proliferation, invasion in vitro, and growth and metastasis in vivo [27].